Skip to main content

Advertisement

SpringerLink
Log in

Intraoperative Teilbrustbestrahlung mit Elektronen (ELIOT) vs. konventionelle Ganzbrustbestrahlung beim invasiven Mammakarzinom im frühen Stadium nach brusterhaltender Operation: Langzeitdaten einer kontrollierten, randomisierten Studie

Intraoperative partial breast irradiation with electrons (ELIOT) compared to conventionally fractionated whole-breast irradiation of early-stage invasive breast cancer after breast-conserving surgery: long-term data from a prospective randomised trial

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Zeitpunkt der Randomisierung bis zum Rezidivereignis

  2. 90 %-Isodose als: a = Radius in der Breite (normal [= 90°] zur Rotationsachse), c = halbe Höhe (gemessen an der Rotationsachse z)

  3. 90 %-Isodose als: r = Radius, h = Höhe

Literatur

  1. Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14(13):1269–1277. https://doi.org/10.1016/s1470-2045(13)70497-2

    Article  PubMed  Google Scholar 

  2. Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, Jereczek-Fossa BA, Cattani F, Sangalli C, Luini A, Caldarella P, Venturino M, Sances D, Zurrida S, Viale G, Leonardi MC, Intra M (2021) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol 22(5):597–608. https://doi.org/10.1016/s1470-2045(21)00080-2

    Article  PubMed  Google Scholar 

  3. Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, White J, Harris JR (2017) Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol 7(2):73–79. https://doi.org/10.1016/j.prro.2016.09.007

    Article  PubMed  Google Scholar 

  4. Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Rotmensz N, Sangalli C, Luini A, Veronesi U, Orecchia R (2012) How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European institute of oncology. Int J Radiat Oncol Biol Phys 83(3):806–813. https://doi.org/10.1016/j.ijrobp.2011.08.014

    Article  PubMed  Google Scholar 

  5. Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgauer M, Lossl K, Polat B, Kovacs G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Potter R, Gall C, Malzer M, Uter W, Polgar C (2016) 5‑year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387(10015):229–238. https://doi.org/10.1016/s0140-6736(15)00471-7

    Article  PubMed  Google Scholar 

  6. Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5‑year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet 390(10099):1048–1060. https://doi.org/10.1016/s0140-6736(17)31145-5

    Article  PubMed  PubMed Central  Google Scholar 

  7. Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, Paiar F, Scotti V, De Luca Cardillo C, Bastiani P, Orzalesi L, Casella D, Sanchez L, Nori J, Fambrini M, Bianchi S (2015) Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5‑year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51(4):451–463. https://doi.org/10.1016/j.ejca.2014.12.013

    Article  PubMed  Google Scholar 

  8. Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA (2019) External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet 394(10215):2165–2172. https://doi.org/10.1016/s0140-6736(19)32515-2

    Article  PubMed  Google Scholar 

  9. Meattini I, Marrazzo L, Saieva C, Desideri I, Scotti V, Simontacchi G, Bonomo P, Greto D, Mangoni M, Scoccianti S, Lucidi S, Paoletti L, Fambrini M, Bernini M, Sanchez L, Orzalesi L, Nori J, Bianchi S, Pallotta S, Livi L (2020) Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial. J Clin Oncol 38(35):4175–4183. https://doi.org/10.1200/jco.20.00650

    Article  PubMed  Google Scholar 

  10. Polgár C, Fodor J, Major T, Sulyok Z, Kásler M (2013) Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108(2):197–202. https://doi.org/10.1016/j.radonc.2013.05.008

    Article  PubMed  Google Scholar 

  11. Fastner G, Gaisberger C, Kaiser J, Scherer P, Ciabattoni A, Petoukhova A, Sperk E, Poortmans P, Calvo FA, Sedlmayer F, Leonardi MC (2020) ESTRO IORT task force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer. Radiother Oncol 149:150–157. https://doi.org/10.1016/j.radonc.2020.04.059

    Article  CAS  PubMed  Google Scholar 

  12. Fastner G, Reitsamer R, Sedlmayer F (2014) Partial breast irradiation with intraoperative electrons versus conventional external whole breast irradiation for early breast cancer. Results of the ELIOT trial. Strahlenther Onkol 190(4):422–424. https://doi.org/10.1007/s00066-014-0556-x

    Article  CAS  PubMed  Google Scholar 

  13. Brenner DJ (1993) Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 26(1):171–179. https://doi.org/10.1016/0360-3016(93)90189-3

    Article  CAS  PubMed  Google Scholar 

  14. Leonardi MC, Maisonneuve P, Mastropasqua MG, Cattani F, Fanetti G, Morra A, Lazzari R, Bazzani F, Caputo M, Rotmensz N, Gerardi MA, Ricotti R, Galimberti VE, Veronesi P, Dicuonzo S, Viale G, Jereczek-Fossa BA, Orecchia R (2017) Comparison of treatment outcome between invasive lobular and ductal carcinomas in patients receiving partial breast irradiation with intraoperative electrons. Int J Radiat Oncol Biol Phys 99(1):173–181. https://doi.org/10.1016/j.ijrobp.2017.04.033

    Article  PubMed  Google Scholar 

  15. Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE (2013) Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British association of surgical oncology (BASO) II trial. Eur J Cancer 49(10):2294–2302. https://doi.org/10.1016/j.ejca.2013.02.031

    Article  CAS  PubMed  Google Scholar 

  16. Fastner G, Sedlmayer F, Widder J, Metz M, Geinitz H, Kapp K, Fesl C, Solkner L, Greil R, Jakesz R, Kwasny W, Heck D, Bjelic-Radisic V, Balic M, Stoger H, Wieder U, Zwrtek R, Semmler D, Horvath W, Melbinger-Zeinitzer E, Wiesholzer M, Wette V, Gnant M (2020) Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian breast and colorectal cancer study group 8A trial. Eur J Cancer 127:12–20. https://doi.org/10.1016/j.ejca.2019.11.024

    Article  CAS  PubMed  Google Scholar 

  17. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387. https://doi.org/10.1200/jco.2012.45.2615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Alco G, Igdem SI, Ercan T, Dincer M, Senturk R, Atilla S, Oral Zengin F, Okkan S (2010) Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy. Br J Radiol 83(996):1072–1076. https://doi.org/10.1259/bjr/25788274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, Fussl C, Haase W, Harms W, Piroth MD, Souchon R, Wenz F, Sauer R (2014) DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol 190(4):342–351. https://doi.org/10.1007/s00066-013-0543-7

    Article  PubMed  Google Scholar 

  20. Gentilini O, Botteri E, Leonardi MC, Rotmensz N, Vila J, Peradze N, Thomazini MV, Jereczek BA, Galimberti V, Luini A, Veronesi P, Orecchia R (2017) Ipsilateral axillary recurrence after breast conservative surgery: the protective effect of whole breast radiotherapy. Radiother Oncol 122(1):37–44. https://doi.org/10.1016/j.radonc.2016.12.021

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Radiotherapie und Radio-Onkologie, Uniklinikum Salzburg, Landeskrankenhaus, Paracelsus Medizinische Privatuniversität, Müllner Hauptstraße 48, 5020, Salzburg, Österreich

    Gerd Fastner M.Sc.,  Christoph Gaisberger,  Markus Stana &  Felix Sedlmayer

  2. Universitätsklinik für Frauenheilkunde und Geburtshilfe – senologische Abteilung, Uniklinikum Salzburg, Landeskrankenhaus, Paracelsus Medizinische Privatuniversität, Salzburg, Österreich

    Roland Reitsamer

Authors
  1. Gerd Fastner M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Reitsamer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christoph Gaisberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Markus Stana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Felix Sedlmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerd Fastner M.Sc..

Ethics declarations

Interessenkonflikt

G. Fastner deklariert Honorare für Vorträge von Roche. F. Sedlmayer deklariert Forschungsgrants von IntraOp Medical und der Krebshilfe Salzburg sowie Honorare für Vorträge von Janssen Cilag, BMS und Astellas. R. Reitsamer, C. Gaisberger und M. Stana geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Orecchia R, Veronesi U, Maisonneuve P et al (2021) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase III equivalence trial. Lancet Oncol 22:597–608.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fastner, G., Reitsamer, R., Gaisberger, C. et al. Intraoperative Teilbrustbestrahlung mit Elektronen (ELIOT) vs. konventionelle Ganzbrustbestrahlung beim invasiven Mammakarzinom im frühen Stadium nach brusterhaltender Operation: Langzeitdaten einer kontrollierten, randomisierten Studie. Strahlenther Onkol 197, 1032–1036 (2021). https://doi.org/10.1007/s00066-021-01848-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-021-01848-4

Search

Navigation